Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2017 · 10-Q
Revenue$1.45M$1.45M+15.5% vs Q2 2016 Net Income$79.04K$79.04KN/M vs Q2 2016 EPS Diluted$0.00$0.00N/M vs Q2 2016 Gross Profit$1,288,580+23.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$46,412N/M Free Cash Flowderived$44,764N/M Margins · derivedGross margin88.7%+5.4 pt vs Q2 2016
Operating margin8.2%+80.0 pt vs Q2 2016
Net margin5.4%+78.8 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end